Stay updated on Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page header. This appears to be a site version update and does not alter the trial content.
    Difference
    0.1%
    Check dated 2026-03-18T19:30:50.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:59.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added revision: v3.4.2 and removed the funding lapse and government operating status notices (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:26.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding affecting data currency has been added, and the page now shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T07:55:54.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and made minor metadata label changes (capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), with the revision header updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:49:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.